Pharmacokinetics of intravenous trimethoprim-sulfamethoxazole in children and adults with normal and impaired renal function.

PubWeight™: 1.20‹?› | Rank: Top 10%

🔗 View Article (PMID 6981173)

Published in Rev Infect Dis on October 12, 1982

Authors

G R Siber, C C Gorham, J F Ericson, A L Smith

Articles citing this

A changing pattern of susceptibility of Xanthomonas maltophilia to antimicrobial agents: implications for therapy. Antimicrob Agents Chemother (1994) 2.10

Single dose pharmacokinetics of trimethoprim. Arch Dis Child (1985) 1.15

Pharmacokinetics of trimethoprim-sulfamethoxazole in critically ill and non-critically ill AIDS patients. Antimicrob Agents Chemother (1995) 0.97

Pharmacokinetics and adverse effects of 20-mg/kg/day trimethoprim and 100-mg/kg/day sulfamethoxazole in healthy adult subjects. Antimicrob Agents Chemother (1991) 0.95

Use of low-dose trimethoprim-sulfamethoxazole thrice weekly for primary and secondary prophylaxis of Pneumocystis carinii pneumonia in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother (1991) 0.95

Pharmacokinetics of trimethoprim and sulfamethoxazole in serum and cerebrospinal fluid of adult patients with normal meninges. Antimicrob Agents Chemother (1984) 0.92

Trimethoprim- sulfamethoxazole: pharmacokinetics, clinical uses, and adverse reactions. Tex Heart Inst J (1990) 0.90

Multiple-dose pharmacokinetics of 12 milligrams of trimethoprim and 60 milligrams of sulfamethoxazole per kilogram of body weight per day in healthy volunteers. Antimicrob Agents Chemother (1993) 0.88

Cotrimoxazole - optimal dosing in the critically ill. Ann Intensive Care (2014) 0.76

Optimization of anti-infective dosing regimens during online haemodiafiltration. Clin Kidney J (2017) 0.75

Suboptimal Cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines. Br J Clin Pharmacol (2017) 0.75

Antiparasitic drugs in children. Clin Pharmacokinet (1989) 0.75

Articles by these authors

Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med (1994) 7.98

Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol (1984) 6.67

A rapid chemical assay for gentamicin. N Engl J Med (1972) 6.36

Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med (1999) 6.23

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis (2000) 5.52

Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94

Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis (2000) 4.93

Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80

Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1984) 4.25

Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature (2000) 4.12

2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor. Bioorg Med Chem Lett (2000) 4.03

Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens. N Engl J Med (1980) 3.95

Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol (1993) 3.82

Improved enzymatic assay of chloramphenicol. Clin Chem (1978) 3.31

Rapid diagnosis of Hemophilus influenzae type b infections by latex particle agglutination and counterimmunoelectrophoresis. J Pediatr (1978) 3.05

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II. Clin Infect Dis (2000) 2.79

Hemophilus influenzae type B susceptibility to 17 antibiotics. J Pediatr (1975) 2.74

Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg (1992) 2.71

Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. J Clin Microbiol (1992) 2.67

Gentamicin:adenine mononucleotide transferase: partial purification, characterization, and use in the clinical quantitation of gentamicin. J Infect Dis (1974) 2.45

Rapid detection of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1981) 2.41

Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob Agents Chemother (1986) 2.38

L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. Biochemistry (2000) 2.36

Is the acetylcholine receptor a rabies virus receptor? Science (1982) 2.30

Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3. Antimicrob Agents Chemother (1988) 2.28

Adjuvants for human vaccines--current status, problems and future prospects. Vaccine (1995) 2.26

Crystal structure of an endotoxin-neutralizing protein from the horseshoe crab, Limulus anti-LPS factor, at 1.5 A resolution. EMBO J (1993) 2.15

Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J Infect Dis (1992) 2.11

Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet (1995) 2.08

Characterization of chloramphenicol-resistant Haemophilus influenzae. Antimicrob Agents Chemother (1980) 2.07

Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch Dis Child (1977) 2.04

Isolation and assay of rabies serogroup viruses in CER cells. Intervirology (1977) 2.03

The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01

Characterization of Haemophilus influenzae type b fimbriae. Infect Immun (1984) 2.00

Antibiotics and invasive Haemophilus influenzae. N Engl J Med (1976) 2.00

Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol (1984) 1.95

The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94

Sepsis and congenital asplenia. J Pediatr (1977) 1.93

T-cell alpha beta + and gamma delta + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium. Proc Natl Acad Sci U S A (1996) 1.92

In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother (1981) 1.87

Impaired antibody response to pneumococcal vaccine after treatment for Hodgkin's disease. N Engl J Med (1978) 1.86

Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis (1985) 1.85

Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis (1991) 1.84

Clinical staging in Reye syndrome. Am J Dis Child (1974) 1.84

A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1985) 1.84

Isolation of field rabies virus strains in CER and murine neuroblastoma cell cultures. Intervirology (1978) 1.81

Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis (1999) 1.79

Lipid peroxidation by human blood phagocytes. J Clin Invest (1974) 1.79

Riboflavin and mouse hepatic cell structure and function. II. Division of mitochondria during recovery from simple deficiency. J Cell Biol (1969) 1.74

A virulent nonencapsulated Haemophilus influenzae. J Infect Dis (1996) 1.73

A first-generation whole genome-radiation hybrid map spanning the mouse genome. Genome Res (1997) 1.73

Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med (1985) 1.73

Interlaboratory study evaluating quantitation of antibodies to Haemophilus influenzae type b polysaccharide by enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol (1996) 1.71

Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J (1995) 1.70

Detection of relatively penicillin G-resistant Neisseria meningitidis by disk susceptibility testing. Antimicrob Agents Chemother (1987) 1.67

Comparative virulence of Haemophilus influenzae with a type b or type d capsule. Infect Immun (1981) 1.66

Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis (1978) 1.65

Respiratory syncytial virus-enriched globulin for the prevention of acute otitis media in high risk children. J Pediatr (1996) 1.65

Increasing incidence of ampicillin resistance in Hemophilus influenzae. J Pediatr (1978) 1.63

Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins. J Infect Dis (1991) 1.62

Bacterial polysaccharide immune globulin for prophylaxis of acute otitis media in high-risk children. J Pediatr (1993) 1.61

Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics. Antimicrob Agents Chemother (1979) 1.60

Urogenital, maternal and neonatal isolates of Haemophilus influenzae: identification of unusually virulent serologically non-typable clone families and evidence for a new Haemophilus species. J Gen Microbiol (1990) 1.59

Disposition of drugs in cystic fibrosis. III. Acetaminophen. Clin Pharmacol Ther (1991) 1.59

Pertussis in Massachusetts, 1981-1991: incidence, serologic diagnosis, and vaccine effectiveness. J Infect Dis (1994) 1.56

Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory. Clin Infect Dis (2008) 1.55

Pigment gallstones form as a composite of bacterial microcolonies and pigment solids. Ann Surg (1987) 1.55

Enhanced detection with an enzyme-linked immunosorbent assay of candida mannan in antibody-containing serum after heat extraction. J Infect Dis (1982) 1.53

Host cell receptors for two strains of Sindbis virus. Arch Virol (1980) 1.51

In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother (1989) 1.49

Characterization of mouse parvovirus infection by in situ hybridization. J Virol (1995) 1.49

Psychiatric disorders in the first-degree relatives of probands with bulimia nervosa. Am J Psychiatry (1989) 1.46

Diagnosis of Wilson's disease: an experience over three decades. Gut (2000) 1.46

Failure of prophylactic and therapeutic use of a murine anti-tumor necrosis factor monoclonal antibody in Escherichia coli sepsis in the rabbit. Crit Care Med (1995) 1.46

A call for health policy education in the medical school curriculum. JAMA (1995) 1.46

Design of a group-randomized Streptococcus pneumoniae vaccine trial. Control Clin Trials (2001) 1.44

Suppression of airway inflammation by a natural acute infection of the intestinal epithelium. Mucosal Immunol (2008) 1.44

Barbiturate protection in cerebral hypoxia. Anesthesiology (1977) 1.44

An immunodeficiency characterized by impaired antibody responses to polysaccharides. N Engl J Med (1987) 1.43

Pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype. Lab Invest (1991) 1.41

Effect of misoprostol on fat malabsorption in cystic fibrosis. Arch Dis Child (1988) 1.41

Cold-passaged, temperature-sensitive mutants of human respiratory syncytial virus (RSV) are highly attenuated, immunogenic, and protective in seronegative chimpanzees, even when RSV antibodies are infused shortly before immunization. Vaccine (1995) 1.40

Group A streptococcal infections of the skin and pharynx (second of two parts). N Engl J Med (1977) 1.39

Angiographic and clinical follow-up of percutaneous revascularization for transplant coronary artery disease. J Invasive Cardiol (2000) 1.39

Pharmacokinetics of gentamicin in children and adults. J Infect Dis (1975) 1.39

Laboratory animal medicine in a time of crisis. Comp Med (2001) 1.39

Evaluation of a rapid beta-lactamase test for detecting ampicillin-resistant strains of Hemophilus influenzae type b. Pediatrics (1976) 1.39

Effect of chloramphenicol administration in drinking water on predictable steady-state serum concentrations of the drug in mice. Comp Med (2000) 1.39

College of American Pathologists and American Society for Reproductive Medicine accreditation of assisted reproductive technology (ART) laboratories is associated with a decrease in take home baby rates of reporting ART laboratories. Fertil Steril (2000) 1.39

Cerebral blood flow and metabolism: effects of anesthetic drugs and techniques. Anesthesiology (1972) 1.39

The cellular and molecular pathogenesis of coronaviruses. Lab Anim Sci (1993) 1.37

Age at primary infection with Salmonella enterica serovar Typhimurium in the chicken influences persistence of infection and subsequent immunity to re-challenge. Vet Immunol Immunopathol (2004) 1.35

Mouse parvovirus infection potentiates rejection of tumor allografts and modulates T cell effector functions. Transplantation (1996) 1.34

Oral chloramphenicol in the treatment of Haemophilus influenzae meningitis. J Pediatr (1981) 1.33

Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b. J Infect Dis (1986) 1.32

Neonatal central nervous system infection due to Mycoplasma hominis. J Pediatr (1977) 1.32

Plasmid-mediated resistance in multiply resistant Haemophilus influenzae type b causing meningitis: molecular characterization of one strain and review of the literature. J Infect Dis (1984) 1.32

Sympatric speciation by allochrony in a seabird. Proc Natl Acad Sci U S A (2007) 1.32